nodes	percent_of_prediction	percent_of_DWPC	metapath
Cladribine—POLE4—skin of body—psoriatic arthritis	0.0115	0.245	CbGeAlD
Cladribine—POLE2—tendon—psoriatic arthritis	0.00768	0.163	CbGeAlD
Cladribine—RRM2B—tendon—psoriatic arthritis	0.00451	0.0957	CbGeAlD
Cladribine—POLE3—tendon—psoriatic arthritis	0.00426	0.0905	CbGeAlD
Cladribine—RRM2—skin of body—psoriatic arthritis	0.00352	0.0747	CbGeAlD
Cladribine—POLE—tendon—psoriatic arthritis	0.00325	0.069	CbGeAlD
Cladribine—RRM1—skin of body—psoriatic arthritis	0.00292	0.062	CbGeAlD
Cladribine—POLA1—tendon—psoriatic arthritis	0.0028	0.0595	CbGeAlD
Cladribine—RRM2—tendon—psoriatic arthritis	0.00268	0.0568	CbGeAlD
Cladribine—RRM1—tendon—psoriatic arthritis	0.00222	0.0472	CbGeAlD
Cladribine—DCK—tendon—psoriatic arthritis	0.00173	0.0367	CbGeAlD
Cladribine—PNP—Clobetasol propionate—Methylprednisolone—psoriatic arthritis	0.00131	0.0381	CbGdCrCtD
Cladribine—PNP—Flunisolide—Methylprednisolone—psoriatic arthritis	0.0013	0.0376	CbGdCrCtD
Cladribine—PNP—Clobetasol propionate—Dexamethasone—psoriatic arthritis	0.00129	0.0375	CbGdCrCtD
Cladribine—PNP—Clobetasol propionate—Betamethasone—psoriatic arthritis	0.00129	0.0375	CbGdCrCtD
Cladribine—PNP—Flunisolide—Betamethasone—psoriatic arthritis	0.00128	0.037	CbGdCrCtD
Cladribine—PNP—Flunisolide—Dexamethasone—psoriatic arthritis	0.00128	0.037	CbGdCrCtD
Cladribine—PNP—Clobetasol propionate—Triamcinolone—psoriatic arthritis	0.00126	0.0366	CbGdCrCtD
Cladribine—PNP—Fluticasone Propionate—Methylprednisolone—psoriatic arthritis	0.00125	0.0363	CbGdCrCtD
Cladribine—PNP—Flunisolide—Triamcinolone—psoriatic arthritis	0.00125	0.0361	CbGdCrCtD
Cladribine—PNP—Fluticasone Propionate—Betamethasone—psoriatic arthritis	0.00123	0.0357	CbGdCrCtD
Cladribine—PNP—Fluticasone Propionate—Dexamethasone—psoriatic arthritis	0.00123	0.0357	CbGdCrCtD
Cladribine—PNP—Fluticasone Propionate—Triamcinolone—psoriatic arthritis	0.0012	0.0349	CbGdCrCtD
Cladribine—PNP—Clobetasol propionate—Prednisone—psoriatic arthritis	0.0012	0.0347	CbGdCrCtD
Cladribine—PNP—Flunisolide—Prednisone—psoriatic arthritis	0.00118	0.0343	CbGdCrCtD
Cladribine—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00118	0.00129	CcSEcCtD
Cladribine—PNP—Fluocinolone Acetonide—Methylprednisolone—psoriatic arthritis	0.00118	0.0342	CbGdCrCtD
Cladribine—Oedema—Prednisolone—psoriatic arthritis	0.00118	0.00128	CcSEcCtD
Cladribine—Neutropenia—Methotrexate—psoriatic arthritis	0.00118	0.00128	CcSEcCtD
Cladribine—PNP—Clobetasol propionate—Prednisolone—psoriatic arthritis	0.00117	0.0339	CbGdCrCtD
Cladribine—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.00117	0.00127	CcSEcCtD
Cladribine—PNP—Fluocinolone Acetonide—Betamethasone—psoriatic arthritis	0.00116	0.0336	CbGdCrCtD
Cladribine—PNP—Fluocinolone Acetonide—Dexamethasone—psoriatic arthritis	0.00116	0.0336	CbGdCrCtD
Cladribine—Cough—Triamcinolone—psoriatic arthritis	0.00116	0.00126	CcSEcCtD
Cladribine—PNP—Flunisolide—Prednisolone—psoriatic arthritis	0.00116	0.0335	CbGdCrCtD
Cladribine—Tachycardia—Prednisolone—psoriatic arthritis	0.00115	0.00125	CcSEcCtD
Cladribine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00114	0.00124	CcSEcCtD
Cladribine—PNP—Fluocinolone Acetonide—Triamcinolone—psoriatic arthritis	0.00113	0.0329	CbGdCrCtD
Cladribine—Myalgia—Triamcinolone—psoriatic arthritis	0.00113	0.00123	CcSEcCtD
Cladribine—Pneumonia—Methotrexate—psoriatic arthritis	0.00113	0.00123	CcSEcCtD
Cladribine—Myalgia—Methylprednisolone—psoriatic arthritis	0.00113	0.00123	CcSEcCtD
Cladribine—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00113	0.00123	CcSEcCtD
Cladribine—Eye disorder—Prednisone—psoriatic arthritis	0.00113	0.00123	CcSEcCtD
Cladribine—Anxiety—Methylprednisolone—psoriatic arthritis	0.00112	0.00122	CcSEcCtD
Cladribine—Infestation NOS—Methotrexate—psoriatic arthritis	0.00112	0.00122	CcSEcCtD
Cladribine—Infestation—Methotrexate—psoriatic arthritis	0.00112	0.00122	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00112	0.00122	CcSEcCtD
Cladribine—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00112	0.00122	CcSEcCtD
Cladribine—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00112	0.00122	CcSEcCtD
Cladribine—Discomfort—Triamcinolone—psoriatic arthritis	0.00112	0.00122	CcSEcCtD
Cladribine—Discomfort—Methylprednisolone—psoriatic arthritis	0.00111	0.00121	CcSEcCtD
Cladribine—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.00111	0.00121	CcSEcCtD
Cladribine—Renal failure—Methotrexate—psoriatic arthritis	0.0011	0.0012	CcSEcCtD
Cladribine—Angiopathy—Prednisone—psoriatic arthritis	0.00109	0.00119	CcSEcCtD
Cladribine—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00109	0.00119	CcSEcCtD
Cladribine—Confusional state—Methylprednisolone—psoriatic arthritis	0.00109	0.00119	CcSEcCtD
Cladribine—Immune system disorder—Prednisone—psoriatic arthritis	0.00109	0.00118	CcSEcCtD
Cladribine—Malaise—Dexamethasone—psoriatic arthritis	0.00109	0.00118	CcSEcCtD
Cladribine—Malaise—Betamethasone—psoriatic arthritis	0.00109	0.00118	CcSEcCtD
Cladribine—Oedema—Triamcinolone—psoriatic arthritis	0.00108	0.00118	CcSEcCtD
Cladribine—Arrhythmia—Prednisone—psoriatic arthritis	0.00108	0.00117	CcSEcCtD
Cladribine—Infection—Triamcinolone—psoriatic arthritis	0.00108	0.00117	CcSEcCtD
Cladribine—Infection—Methylprednisolone—psoriatic arthritis	0.00107	0.00117	CcSEcCtD
Cladribine—Insomnia—Prednisolone—psoriatic arthritis	0.00107	0.00116	CcSEcCtD
Cladribine—Alopecia—Prednisone—psoriatic arthritis	0.00106	0.00116	CcSEcCtD
Cladribine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00106	0.00115	CcSEcCtD
Cladribine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00106	0.00115	CcSEcCtD
Cladribine—Epistaxis—Methotrexate—psoriatic arthritis	0.00106	0.00115	CcSEcCtD
Cladribine—Paraesthesia—Prednisolone—psoriatic arthritis	0.00106	0.00115	CcSEcCtD
Cladribine—Tachycardia—Triamcinolone—psoriatic arthritis	0.00106	0.00115	CcSEcCtD
Cladribine—Mental disorder—Prednisone—psoriatic arthritis	0.00106	0.00115	CcSEcCtD
Cladribine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00105	0.00115	CcSEcCtD
Cladribine—PNP—Fluocinolone Acetonide—Prednisolone—psoriatic arthritis	0.00105	0.0304	CbGdCrCtD
Cladribine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00105	0.00114	CcSEcCtD
Cladribine—Malnutrition—Prednisone—psoriatic arthritis	0.00105	0.00114	CcSEcCtD
Cladribine—Erythema—Prednisone—psoriatic arthritis	0.00105	0.00114	CcSEcCtD
Cladribine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00105	0.00114	CcSEcCtD
Cladribine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00104	0.00114	CcSEcCtD
Cladribine—Myalgia—Betamethasone—psoriatic arthritis	0.00103	0.00112	CcSEcCtD
Cladribine—Myalgia—Dexamethasone—psoriatic arthritis	0.00103	0.00112	CcSEcCtD
Cladribine—Anxiety—Betamethasone—psoriatic arthritis	0.00102	0.00111	CcSEcCtD
Cladribine—Anxiety—Dexamethasone—psoriatic arthritis	0.00102	0.00111	CcSEcCtD
Cladribine—Discomfort—Dexamethasone—psoriatic arthritis	0.00101	0.0011	CcSEcCtD
Cladribine—Discomfort—Betamethasone—psoriatic arthritis	0.00101	0.0011	CcSEcCtD
Cladribine—Haemoglobin—Methotrexate—psoriatic arthritis	0.00101	0.0011	CcSEcCtD
Cladribine—Hypotension—Methylprednisolone—psoriatic arthritis	0.00101	0.0011	CcSEcCtD
Cladribine—Pain—Prednisolone—psoriatic arthritis	0.00101	0.0011	CcSEcCtD
Cladribine—Haemorrhage—Methotrexate—psoriatic arthritis	0.00101	0.0011	CcSEcCtD
Cladribine—Pharyngitis—Methotrexate—psoriatic arthritis	0.000999	0.00109	CcSEcCtD
Cladribine—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000994	0.00108	CcSEcCtD
Cladribine—Urethral disorder—Methotrexate—psoriatic arthritis	0.000987	0.00107	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000987	0.00107	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000984	0.00107	CcSEcCtD
Cladribine—Oedema—Betamethasone—psoriatic arthritis	0.000983	0.00107	CcSEcCtD
Cladribine—Oedema—Dexamethasone—psoriatic arthritis	0.000983	0.00107	CcSEcCtD
Cladribine—Insomnia—Triamcinolone—psoriatic arthritis	0.000979	0.00107	CcSEcCtD
Cladribine—Insomnia—Methylprednisolone—psoriatic arthritis	0.000977	0.00106	CcSEcCtD
Cladribine—Infection—Dexamethasone—psoriatic arthritis	0.000976	0.00106	CcSEcCtD
Cladribine—Infection—Betamethasone—psoriatic arthritis	0.000976	0.00106	CcSEcCtD
Cladribine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000973	0.00106	CcSEcCtD
Cladribine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000972	0.00106	CcSEcCtD
Cladribine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00097	0.00106	CcSEcCtD
Cladribine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00097	0.00106	CcSEcCtD
Cladribine—Anaemia—Prednisone—psoriatic arthritis	0.000969	0.00106	CcSEcCtD
Cladribine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000965	0.00105	CcSEcCtD
Cladribine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000964	0.00105	CcSEcCtD
Cladribine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000964	0.00105	CcSEcCtD
Cladribine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000962	0.00105	CcSEcCtD
Cladribine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000962	0.00105	CcSEcCtD
Cladribine—Tachycardia—Betamethasone—psoriatic arthritis	0.000959	0.00104	CcSEcCtD
Cladribine—Tachycardia—Dexamethasone—psoriatic arthritis	0.000959	0.00104	CcSEcCtD
Cladribine—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000952	0.00104	CcSEcCtD
Cladribine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00095	0.00103	CcSEcCtD
Cladribine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00095	0.00103	CcSEcCtD
Cladribine—Malaise—Prednisone—psoriatic arthritis	0.000946	0.00103	CcSEcCtD
Cladribine—Eye disorder—Methotrexate—psoriatic arthritis	0.000941	0.00102	CcSEcCtD
Cladribine—Anorexia—Dexamethasone—psoriatic arthritis	0.000937	0.00102	CcSEcCtD
Cladribine—Anorexia—Betamethasone—psoriatic arthritis	0.000937	0.00102	CcSEcCtD
Cladribine—Urticaria—Prednisolone—psoriatic arthritis	0.000936	0.00102	CcSEcCtD
Cladribine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000934	0.00102	CcSEcCtD
Cladribine—Fatigue—Triamcinolone—psoriatic arthritis	0.000934	0.00102	CcSEcCtD
Cladribine—Fatigue—Methylprednisolone—psoriatic arthritis	0.000932	0.00101	CcSEcCtD
Cladribine—Pain—Triamcinolone—psoriatic arthritis	0.000926	0.00101	CcSEcCtD
Cladribine—Hypotension—Betamethasone—psoriatic arthritis	0.000918	0.001	CcSEcCtD
Cladribine—Hypotension—Dexamethasone—psoriatic arthritis	0.000918	0.001	CcSEcCtD
Cladribine—Angiopathy—Methotrexate—psoriatic arthritis	0.000913	0.000994	CcSEcCtD
Cladribine—Immune system disorder—Methotrexate—psoriatic arthritis	0.000909	0.00099	CcSEcCtD
Cladribine—PNP—Danazol—Prednisone—psoriatic arthritis	0.000907	0.0263	CbGdCrCtD
Cladribine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000907	0.000988	CcSEcCtD
Cladribine—Chills—Methotrexate—psoriatic arthritis	0.000903	0.000983	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000895	0.000975	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000895	0.000975	CcSEcCtD
Cladribine—Arthralgia—Prednisone—psoriatic arthritis	0.000893	0.000972	CcSEcCtD
Cladribine—Myalgia—Prednisone—psoriatic arthritis	0.000893	0.000972	CcSEcCtD
Cladribine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000892	0.000972	CcSEcCtD
Cladribine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00089	0.00097	CcSEcCtD
Cladribine—Anxiety—Prednisone—psoriatic arthritis	0.00089	0.000969	CcSEcCtD
Cladribine—Alopecia—Methotrexate—psoriatic arthritis	0.000889	0.000969	CcSEcCtD
Cladribine—Insomnia—Dexamethasone—psoriatic arthritis	0.000889	0.000968	CcSEcCtD
Cladribine—Insomnia—Betamethasone—psoriatic arthritis	0.000889	0.000968	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000886	0.000965	CcSEcCtD
Cladribine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000884	0.000962	CcSEcCtD
Cladribine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000882	0.000961	CcSEcCtD
Cladribine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000882	0.000961	CcSEcCtD
Cladribine—Discomfort—Prednisone—psoriatic arthritis	0.000882	0.00096	CcSEcCtD
Cladribine—Mental disorder—Methotrexate—psoriatic arthritis	0.000882	0.00096	CcSEcCtD
Cladribine—Erythema—Methotrexate—psoriatic arthritis	0.000876	0.000954	CcSEcCtD
Cladribine—Malnutrition—Methotrexate—psoriatic arthritis	0.000876	0.000954	CcSEcCtD
Cladribine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000868	0.000945	CcSEcCtD
Cladribine—Urticaria—Triamcinolone—psoriatic arthritis	0.00086	0.000937	CcSEcCtD
Cladribine—Urticaria—Methylprednisolone—psoriatic arthritis	0.000858	0.000935	CcSEcCtD
Cladribine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000856	0.000932	CcSEcCtD
Cladribine—Oedema—Prednisone—psoriatic arthritis	0.000856	0.000932	CcSEcCtD
Cladribine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000854	0.00093	CcSEcCtD
Cladribine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000854	0.00093	CcSEcCtD
Cladribine—Decreased appetite—Betamethasone—psoriatic arthritis	0.000854	0.00093	CcSEcCtD
Cladribine—Infection—Prednisone—psoriatic arthritis	0.00085	0.000926	CcSEcCtD
Cladribine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000848	0.000924	CcSEcCtD
Cladribine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000848	0.000924	CcSEcCtD
Cladribine—Back pain—Methotrexate—psoriatic arthritis	0.000848	0.000923	CcSEcCtD
Cladribine—Fatigue—Dexamethasone—psoriatic arthritis	0.000847	0.000922	CcSEcCtD
Cladribine—Fatigue—Betamethasone—psoriatic arthritis	0.000847	0.000922	CcSEcCtD
Cladribine—Pain—Dexamethasone—psoriatic arthritis	0.00084	0.000915	CcSEcCtD
Cladribine—Pain—Betamethasone—psoriatic arthritis	0.00084	0.000915	CcSEcCtD
Cladribine—Nervous system disorder—Prednisone—psoriatic arthritis	0.000839	0.000914	CcSEcCtD
Cladribine—Tachycardia—Prednisone—psoriatic arthritis	0.000835	0.000909	CcSEcCtD
Cladribine—Skin disorder—Prednisone—psoriatic arthritis	0.000831	0.000905	CcSEcCtD
Cladribine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000827	0.000901	CcSEcCtD
Cladribine—Anorexia—Prednisone—psoriatic arthritis	0.000816	0.000888	CcSEcCtD
Cladribine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000813	0.000885	CcSEcCtD
Cladribine—Anaemia—Methotrexate—psoriatic arthritis	0.00081	0.000882	CcSEcCtD
Cladribine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00081	0.000882	CcSEcCtD
Cladribine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00081	0.000882	CcSEcCtD
Cladribine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000803	0.000875	CcSEcCtD
Cladribine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000803	0.000875	CcSEcCtD
Cladribine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000798	0.000869	CcSEcCtD
Cladribine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000796	0.000867	CcSEcCtD
Cladribine—Malaise—Methotrexate—psoriatic arthritis	0.00079	0.00086	CcSEcCtD
Cladribine—Urticaria—Betamethasone—psoriatic arthritis	0.000781	0.00085	CcSEcCtD
Cladribine—Urticaria—Dexamethasone—psoriatic arthritis	0.000781	0.00085	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00078	0.000849	CcSEcCtD
Cladribine—Dizziness—Prednisolone—psoriatic arthritis	0.000779	0.000848	CcSEcCtD
Cladribine—Asthenia—Triamcinolone—psoriatic arthritis	0.000777	0.000846	CcSEcCtD
Cladribine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000777	0.000846	CcSEcCtD
Cladribine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000777	0.000846	CcSEcCtD
Cladribine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000777	0.000846	CcSEcCtD
Cladribine—Body temperature increased—Betamethasone—psoriatic arthritis	0.000777	0.000846	CcSEcCtD
Cladribine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000775	0.000844	CcSEcCtD
Cladribine—Insomnia—Prednisone—psoriatic arthritis	0.000774	0.000843	CcSEcCtD
Cladribine—Paraesthesia—Prednisone—psoriatic arthritis	0.000768	0.000837	CcSEcCtD
Cladribine—Pruritus—Triamcinolone—psoriatic arthritis	0.000766	0.000834	CcSEcCtD
Cladribine—Cough—Methotrexate—psoriatic arthritis	0.000765	0.000833	CcSEcCtD
Cladribine—Pruritus—Methylprednisolone—psoriatic arthritis	0.000764	0.000832	CcSEcCtD
Cladribine—Myalgia—Methotrexate—psoriatic arthritis	0.000746	0.000812	CcSEcCtD
Cladribine—Arthralgia—Methotrexate—psoriatic arthritis	0.000746	0.000812	CcSEcCtD
Cladribine—Chest pain—Methotrexate—psoriatic arthritis	0.000746	0.000812	CcSEcCtD
Cladribine—Decreased appetite—Prednisone—psoriatic arthritis	0.000744	0.00081	CcSEcCtD
Cladribine—Rash—Prednisolone—psoriatic arthritis	0.000742	0.000808	CcSEcCtD
Cladribine—Dermatitis—Prednisolone—psoriatic arthritis	0.000742	0.000808	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000741	0.000807	CcSEcCtD
Cladribine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000739	0.000805	CcSEcCtD
Cladribine—Fatigue—Prednisone—psoriatic arthritis	0.000738	0.000803	CcSEcCtD
Cladribine—Headache—Prednisolone—psoriatic arthritis	0.000738	0.000803	CcSEcCtD
Cladribine—Discomfort—Methotrexate—psoriatic arthritis	0.000737	0.000803	CcSEcCtD
Cladribine—Constipation—Prednisone—psoriatic arthritis	0.000732	0.000797	CcSEcCtD
Cladribine—Confusional state—Methotrexate—psoriatic arthritis	0.000721	0.000785	CcSEcCtD
Cladribine—Dizziness—Triamcinolone—psoriatic arthritis	0.000716	0.00078	CcSEcCtD
Cladribine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000715	0.000778	CcSEcCtD
Cladribine—DCK—Desoximetasone—Methylprednisolone—psoriatic arthritis	0.000712	0.0206	CbGdCrCtD
Cladribine—Infection—Methotrexate—psoriatic arthritis	0.00071	0.000774	CcSEcCtD
Cladribine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000705	0.000768	CcSEcCtD
Cladribine—Asthenia—Betamethasone—psoriatic arthritis	0.000705	0.000768	CcSEcCtD
Cladribine—Asthenia—Dexamethasone—psoriatic arthritis	0.000705	0.000768	CcSEcCtD
Cladribine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000701	0.000764	CcSEcCtD
Cladribine—DCK—Desoximetasone—Dexamethasone—psoriatic arthritis	0.000701	0.0203	CbGdCrCtD
Cladribine—DCK—Desoximetasone—Betamethasone—psoriatic arthritis	0.000701	0.0203	CbGdCrCtD
Cladribine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.0007	0.000762	CcSEcCtD
Cladribine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.0007	0.000762	CcSEcCtD
Cladribine—Nausea—Prednisolone—psoriatic arthritis	0.000699	0.000762	CcSEcCtD
Cladribine—Pruritus—Betamethasone—psoriatic arthritis	0.000695	0.000757	CcSEcCtD
Cladribine—Pruritus—Dexamethasone—psoriatic arthritis	0.000695	0.000757	CcSEcCtD
Cladribine—Skin disorder—Methotrexate—psoriatic arthritis	0.000695	0.000756	CcSEcCtD
Cladribine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000691	0.000753	CcSEcCtD
Cladribine—DCK—Diflorasone—Methylprednisolone—psoriatic arthritis	0.000691	0.02	CbGdCrCtD
Cladribine—Vomiting—Triamcinolone—psoriatic arthritis	0.000689	0.00075	CcSEcCtD
Cladribine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000687	0.000748	CcSEcCtD
Cladribine—DCK—Desoximetasone—Triamcinolone—psoriatic arthritis	0.000685	0.0198	CbGdCrCtD
Cladribine—Rash—Triamcinolone—psoriatic arthritis	0.000683	0.000744	CcSEcCtD
Cladribine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000682	0.000743	CcSEcCtD
Cladribine—Anorexia—Methotrexate—psoriatic arthritis	0.000682	0.000742	CcSEcCtD
Cladribine—Rash—Methylprednisolone—psoriatic arthritis	0.000681	0.000742	CcSEcCtD
Cladribine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000681	0.000741	CcSEcCtD
Cladribine—DCK—Diflorasone—Dexamethasone—psoriatic arthritis	0.00068	0.0197	CbGdCrCtD
Cladribine—DCK—Diflorasone—Betamethasone—psoriatic arthritis	0.00068	0.0197	CbGdCrCtD
Cladribine—Urticaria—Prednisone—psoriatic arthritis	0.00068	0.00074	CcSEcCtD
Cladribine—Headache—Triamcinolone—psoriatic arthritis	0.000678	0.000739	CcSEcCtD
Cladribine—Headache—Methylprednisolone—psoriatic arthritis	0.000677	0.000737	CcSEcCtD
Cladribine—Body temperature increased—Prednisone—psoriatic arthritis	0.000676	0.000737	CcSEcCtD
Cladribine—Abdominal pain—Prednisone—psoriatic arthritis	0.000676	0.000737	CcSEcCtD
Cladribine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000672	0.000732	CcSEcCtD
Cladribine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000672	0.000732	CcSEcCtD
Cladribine—Hypotension—Methotrexate—psoriatic arthritis	0.000668	0.000728	CcSEcCtD
Cladribine—DCK—Diflorasone—Triamcinolone—psoriatic arthritis	0.000665	0.0192	CbGdCrCtD
Cladribine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000652	0.000709	CcSEcCtD
Cladribine—DCK—Desoximetasone—Prednisone—psoriatic arthritis	0.00065	0.0188	CbGdCrCtD
Cladribine—Dizziness—Dexamethasone—psoriatic arthritis	0.00065	0.000708	CcSEcCtD
Cladribine—Dizziness—Betamethasone—psoriatic arthritis	0.00065	0.000708	CcSEcCtD
Cladribine—Insomnia—Methotrexate—psoriatic arthritis	0.000647	0.000704	CcSEcCtD
Cladribine—Nausea—Triamcinolone—psoriatic arthritis	0.000643	0.0007	CcSEcCtD
Cladribine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000642	0.000699	CcSEcCtD
Cladribine—Nausea—Methylprednisolone—psoriatic arthritis	0.000642	0.000699	CcSEcCtD
Cladribine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000638	0.000694	CcSEcCtD
Cladribine—Somnolence—Methotrexate—psoriatic arthritis	0.000636	0.000692	CcSEcCtD
Cladribine—DCK—Desoximetasone—Prednisolone—psoriatic arthritis	0.000634	0.0184	CbGdCrCtD
Cladribine—DCK—Diflorasone—Prednisone—psoriatic arthritis	0.000631	0.0183	CbGdCrCtD
Cladribine—Hypersensitivity—Prednisone—psoriatic arthritis	0.00063	0.000687	CcSEcCtD
Cladribine—Vomiting—Dexamethasone—psoriatic arthritis	0.000625	0.00068	CcSEcCtD
Cladribine—Vomiting—Betamethasone—psoriatic arthritis	0.000625	0.00068	CcSEcCtD
Cladribine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000622	0.000677	CcSEcCtD
Cladribine—Rash—Dexamethasone—psoriatic arthritis	0.00062	0.000675	CcSEcCtD
Cladribine—Rash—Betamethasone—psoriatic arthritis	0.00062	0.000675	CcSEcCtD
Cladribine—Dermatitis—Betamethasone—psoriatic arthritis	0.000619	0.000674	CcSEcCtD
Cladribine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000619	0.000674	CcSEcCtD
Cladribine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000617	0.000672	CcSEcCtD
Cladribine—Fatigue—Methotrexate—psoriatic arthritis	0.000617	0.000671	CcSEcCtD
Cladribine—DCK—Diflorasone—Prednisolone—psoriatic arthritis	0.000616	0.0178	CbGdCrCtD
Cladribine—Headache—Dexamethasone—psoriatic arthritis	0.000616	0.00067	CcSEcCtD
Cladribine—Headache—Betamethasone—psoriatic arthritis	0.000616	0.00067	CcSEcCtD
Cladribine—Asthenia—Prednisone—psoriatic arthritis	0.000614	0.000669	CcSEcCtD
Cladribine—Pain—Methotrexate—psoriatic arthritis	0.000612	0.000666	CcSEcCtD
Cladribine—Pruritus—Prednisone—psoriatic arthritis	0.000605	0.000659	CcSEcCtD
Cladribine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000589	0.000642	CcSEcCtD
Cladribine—Diarrhoea—Prednisone—psoriatic arthritis	0.000585	0.000638	CcSEcCtD
Cladribine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000585	0.000637	CcSEcCtD
Cladribine—Nausea—Betamethasone—psoriatic arthritis	0.000584	0.000636	CcSEcCtD
Cladribine—Nausea—Dexamethasone—psoriatic arthritis	0.000584	0.000636	CcSEcCtD
Cladribine—Urticaria—Methotrexate—psoriatic arthritis	0.000568	0.000619	CcSEcCtD
Cladribine—Dizziness—Prednisone—psoriatic arthritis	0.000566	0.000616	CcSEcCtD
Cladribine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000565	0.000616	CcSEcCtD
Cladribine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000565	0.000616	CcSEcCtD
Cladribine—Vomiting—Prednisone—psoriatic arthritis	0.000544	0.000592	CcSEcCtD
Cladribine—Rash—Prednisone—psoriatic arthritis	0.00054	0.000588	CcSEcCtD
Cladribine—Dermatitis—Prednisone—psoriatic arthritis	0.000539	0.000587	CcSEcCtD
Cladribine—Headache—Prednisone—psoriatic arthritis	0.000536	0.000584	CcSEcCtD
Cladribine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000527	0.000574	CcSEcCtD
Cladribine—Asthenia—Methotrexate—psoriatic arthritis	0.000513	0.000559	CcSEcCtD
Cladribine—Nausea—Prednisone—psoriatic arthritis	0.000508	0.000553	CcSEcCtD
Cladribine—Pruritus—Methotrexate—psoriatic arthritis	0.000506	0.000551	CcSEcCtD
Cladribine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000489	0.000533	CcSEcCtD
Cladribine—Dizziness—Methotrexate—psoriatic arthritis	0.000473	0.000515	CcSEcCtD
Cladribine—Vomiting—Methotrexate—psoriatic arthritis	0.000455	0.000495	CcSEcCtD
Cladribine—Rash—Methotrexate—psoriatic arthritis	0.000451	0.000491	CcSEcCtD
Cladribine—Dermatitis—Methotrexate—psoriatic arthritis	0.00045	0.000491	CcSEcCtD
Cladribine—Headache—Methotrexate—psoriatic arthritis	0.000448	0.000488	CcSEcCtD
Cladribine—Nausea—Methotrexate—psoriatic arthritis	0.000425	0.000463	CcSEcCtD
